Ocular myasthenia gravis is a form of autoimmune disease that causes weakness specifically in the muscles controlling the eyes and eyelids, leading to symptoms like drooping eyelids and double vision that can significantly disrupt daily life.
What is Ocular Myasthenia Gravis?
Ocular myasthenia gravis is a condition in which the muscles that control eye movement and eyelid function become easily tired and weakened. Unlike the generalized form of myasthenia gravis that affects muscles throughout the body, ocular myasthenia gravis limits its effects to the eye region. This means people with this condition experience problems with their vision and eye control, but they do not have difficulty swallowing, speaking, breathing, or weakness in their arms and legs.[1][4]
The condition occurs when the body’s immune system mistakenly attacks the connection between nerves and muscles. In healthy individuals, nerves send signals to muscles using a chemical messenger called acetylcholine. This chemical tells the muscles when to contract and move. In people with ocular myasthenia gravis, the immune system produces antibodies that interfere with the muscles’ ability to receive these signals properly. When the receptors for acetylcholine cannot work as they should, the affected eye muscles tire very easily.[1][5]
What makes eye muscles particularly vulnerable to this condition is that they are structurally different from muscles elsewhere in the body. They have fewer acetylcholine receptors, which is precisely where the immune system’s attack causes problems. Additionally, eye muscles contract much more rapidly than other muscles in the body, which may make them more prone to fatigue even without an underlying disease.[4]
Epidemiology
The overall incidence of ocular myasthenia gravis is approximately 1.13 per 100,000 people per year, based on population studies. When looking at myasthenia gravis more broadly, studies have reported incidence rates ranging from 0.17 to 7 per 100,000 per year. These variations may reflect differences in how cases are identified and reported across different regions and healthcare systems.[2]
Almost half of all people with myasthenia gravis initially present with only ocular symptoms when they first seek medical care. Ocular manifestations occur in 15 to 50 percent of all myasthenia gravis cases, typically appearing as fluctuating drooping of the eyelids, double vision, and weakness of the muscles around the eyes. For some individuals, about 15 percent of those who first experience eye symptoms, the condition remains purely ocular even years after diagnosis. However, in the remaining 85 percent of patients, symptoms of weakness will develop in other parts of the body, usually within the first three years after the initial eye symptoms appear.[1][2]
The condition can affect people of different ages and both men and women. However, certain patterns have been observed. Ocular myasthenia gravis often presents in women under 40 years of age and in men over 60 years of age. Myasthenia gravis overall affects about 20 out of every 100,000 people around the world, and in the United States, approximately 60,000 people are affected at any given time. The actual number may be higher because some people with mild cases may not realize they have the condition or may not seek medical attention.[3][13]
Causes
Ocular myasthenia gravis is an autoimmune condition, meaning the body’s immune system mistakenly identifies its own healthy tissue as foreign and attacks it. In this case, the immune system produces autoantibodies that target proteins located at the neuromuscular junction, the specialized area where nerve cells connect with muscle cells.[2]
In people with ocular myasthenia gravis, these antibodies most commonly attack the acetylcholine receptor on the muscle surface. About 50 percent of people with purely ocular symptoms test positive for antibodies against the acetylcholine receptor. When the disease is more widespread throughout the body, approximately 90 percent of patients have these antibodies. Other types of antibodies can also be involved, including those against muscle-specific tyrosine kinase (called MuSK antibodies) and low-density lipoprotein receptor-related protein 4 (LRP4). Scientists have also detected antibodies against other proteins such as cortactin and agrin, though the exact role these play in causing disease is not yet fully understood.[2][4]
When these antibodies bind to or destroy the receptors on muscle cells, the muscles cannot properly receive the signals sent by nerves. Normally, when you want to move your eyes or blink, your brain sends an electrical signal down a nerve. At the end of the nerve, a chemical called acetylcholine is released into the small gap between the nerve and muscle. This chemical crosses the gap and attaches to receptors on the muscle, which triggers the muscle to contract. In ocular myasthenia gravis, because many of these receptors are blocked or destroyed by antibodies, the signal doesn’t get through effectively, and the muscle becomes weak and tires easily.[5][7]
The underlying reason why the immune system begins producing these harmful antibodies is not completely understood. It is not an infectious disease, so it cannot be transmitted from one person to another. The condition is not caused by a specific behavior or lifestyle choice. Some people may have a genetic predisposition that makes them more likely to develop autoimmune conditions, but ocular myasthenia gravis itself is not directly inherited in a predictable pattern.[3]
Risk Factors
There are no clearly defined risk factors that have been proven to cause ocular myasthenia gravis. However, people who have a family history of myasthenia gravis may be at somewhat greater risk to develop the disease themselves, suggesting that genetic factors may play a role in susceptibility.[5]
Certain demographic patterns are observed in who develops ocular myasthenia gravis. The condition can affect individuals at any age, but it more commonly presents in women who are younger than 40 years old and in men who are older than 60 years. This gender and age pattern suggests that hormonal or age-related factors may influence disease development, though the exact mechanisms remain unclear.[13]
People who already have other autoimmune disorders may be at increased risk of developing myasthenia gravis, including the ocular form. Autoimmune diseases tend to cluster in individuals and families, meaning that having one autoimmune condition can make it more likely to develop another. However, this is not a guarantee, and many people with ocular myasthenia gravis have no other autoimmune conditions.[13]
It is also worth noting that the thymus gland, a small organ in the chest that plays a role in immune system development, is often abnormal in people with myasthenia gravis. Some patients may have an enlarged thymus or, less commonly, a tumor of the thymus called a thymoma. For this reason, when myasthenia gravis is diagnosed, doctors typically perform a CT scan of the chest to examine the thymus gland.[1]
Symptoms
The symptoms of ocular myasthenia gravis are limited to problems with the eyes and eyelids. If you have this condition, you are likely to experience double vision, drooping eyelids, or both. These symptoms are directly caused by weakness in the muscles that control eye movement and eyelid position.[4]
Double vision, medically called diplopia, occurs when your eyes do not move together in a balanced and coordinated way. The brain carefully controls the eye muscles to keep both eyes aligned so that they point at the same object. When the eye muscles become weak, this alignment is disrupted, and the eyes may point in slightly different directions. As a result, each eye sees the same object in a different location, and your brain perceives two separate images instead of one. This can make reading, watching television, driving, and performing other daily activities very challenging.[1][4]
Drooping eyelids, known medically as ptosis, happen when the muscle that lifts the eyelid becomes weak. One or both of your eyelids may droop to cover all or part of the pupil, which can obstruct your vision. The degree of drooping can vary throughout the day and may worsen as you become more tired. Some people find their eyelids droop so much that they have difficulty keeping their eyes open, which obviously interferes with vision and daily functioning.[4][6]
Trouble focusing is another symptom that people with ocular myasthenia gravis may experience. Your eyes may feel strained or fatigued, especially after reading or doing tasks that require sustained visual attention. You might notice that you have difficulty maintaining focus when trying to concentrate on something for a prolonged period.[5]
One of the hallmark features of myasthenia gravis, including the ocular form, is that symptoms fluctuate. Eye weakness often changes from day to day and even throughout a single day. Problems with the eyes are typically worse at the end of the day or after the eyes have been used extensively. For example, you might notice that your eyelids droop more in the evening or that double vision worsens after spending several hours reading or working at a computer. Conversely, symptoms often improve with rest. You may find that your eye problems are temporarily better if you close your eyes and rest for several minutes when symptoms are troubling you.[4][17]
Importantly, if you have ocular myasthenia gravis, you will not have difficulty swallowing, speaking, or breathing, and you will not experience weakness in your arms and legs. These symptoms are characteristic of generalized myasthenia gravis, not the purely ocular form. However, it is important to monitor for the development of symptoms outside the eyes, especially in the first few years after diagnosis, as the condition can progress to the generalized form in some people.[4]
Prevention
Because the exact cause of ocular myasthenia gravis is not fully understood, and because it is an autoimmune condition rather than one caused by infection or lifestyle factors, there are no known measures that can prevent the disease from developing. Unlike conditions that can be prevented through vaccination, dietary changes, or avoiding certain exposures, ocular myasthenia gravis appears to arise from a complex interplay of genetic susceptibility and immune system dysfunction that cannot currently be prevented.[3]
However, once diagnosed with ocular myasthenia gravis, there are steps you can take to manage your symptoms and potentially reduce the frequency and severity of symptom flare-ups. Avoiding extreme temperatures, both hot and cold, can be helpful, as temperature extremes are known to worsen muscle weakness. Getting adequate rest is crucial, as fatigue is a major trigger for worsening symptoms. Learning to pace yourself throughout the day and taking breaks before you become overtired can help you maintain better function.[14][16]
Managing stress is another important aspect of living with ocular myasthenia gravis. Emotional stress and highly charged situations can exacerbate symptoms, so adopting stress-reduction techniques such as meditation, mindfulness, or other relaxation practices may be beneficial. Living as calm and balanced a life as possible can help keep symptoms more stable.[14][16]
It is also important to avoid certain medications that are known to worsen myasthenia gravis. Some antibiotics, heart medications, anesthetics, and other drugs can interfere with neuromuscular transmission and make symptoms worse. Always inform any doctor treating you that you have ocular myasthenia gravis, and check with your neurologist before starting any new medication to ensure it is safe for you to take.[14]
Regular follow-up with your neurologist is essential for monitoring the course of your condition and adjusting treatment as needed. Early detection of any spread of symptoms beyond the eyes allows for timely intervention and better management. Although you cannot prevent the disease itself, proactive management and careful monitoring can help you maintain the best possible quality of life.[15]
How Ocular Myasthenia Gravis is Diagnosed
Diagnosing ocular myasthenia gravis involves several steps and often requires a combination of clinical examination, blood tests, and specialized neurological testing. Your doctor will begin by asking detailed questions about your symptoms, including when they started, how they have changed over time, what makes them better or worse, and how they affect your daily life. This medical history is crucial because the pattern of symptoms that fluctuate with activity and improve with rest is highly suggestive of myasthenia gravis.[1]
A thorough physical examination follows, during which your doctor will carefully test your eyelids and eye movements. They will look for signs of muscle weakness, observe what happens to the muscles when they are fatigued, and note whether strength returns after a period of rest. This examination helps to document the specific patterns of weakness characteristic of myasthenia gravis.[1]
One simple clinical test that can be performed in the office is the ice test. Placing an ice pack over a drooping eyelid for a few minutes can temporarily improve the ptosis if it is caused by myasthenia gravis. The cold temperature appears to help the neuromuscular junction function better temporarily, and improvement with the ice test supports the diagnosis.[2][13]
Blood tests are an important part of the diagnostic workup. Your doctor will order tests to check for the presence of antibodies associated with myasthenia gravis. The most common antibody test looks for anti-acetylcholine receptor antibodies. However, it is important to understand that this blood test has lower accuracy in people with purely ocular symptoms compared to those with generalized disease. About 50 percent of people with ocular myasthenia gravis test positive for these antibodies, which means about half will have a negative result even though they have the disease. A negative antibody test does not rule out ocular myasthenia gravis and may require additional testing.[1][4]
Specialized electrical tests of nerve and muscle function can be very helpful in confirming the diagnosis. One test is called repetitive nerve stimulation, part of a nerve conduction study or electromyogram (EMG). During this test, small electrical stimulations are delivered to a nerve, and the responses are measured from a muscle. In myasthenia gravis, the muscle response tends to decrease with repeated stimulation, showing a characteristic pattern of fatigue.[1]
The most accurate and sensitive electrophysiological test for diagnosing myasthenia gravis is called single fiber electromyography (SFEMG). This test uses very small needles that can measure responses from two nearby muscle fibers. SFEMG is particularly valuable when other tests are inconclusive. When performed by experienced technicians and interpreted by specialists, SFEMG can detect abnormalities in neuromuscular transmission even when other tests are normal.[1][2]
Many people with ocular myasthenia gravis first consult an optometrist or eye doctor about their vision problems. Eye care professionals are often the first to suspect myasthenia gravis based on the characteristic symptoms and will refer patients to a neurologist for further evaluation and testing. A careful eye examination can also help rule out other causes of double vision and drooping eyelids.[4][13]
Once myasthenia gravis is diagnosed, your doctor may order a CT scan of your chest to examine the thymus gland. The thymus is often abnormal in people with myasthenia gravis, and identifying abnormalities such as enlargement or a thymoma (a tumor of the thymus) is important for guiding treatment decisions.[1]
Treatment Options
Treatment for ocular myasthenia gravis aims to relieve symptoms such as drooping eyelids and double vision, improve quality of life, and potentially prevent progression to generalized myasthenia gravis. Several medication options and supportive strategies are available, and treatment plans are individualized based on the severity of symptoms and how much they interfere with daily activities.[8]
Medications
One of the first medications commonly prescribed for ocular myasthenia gravis is pyridostigmine, sold under the brand name Mestinon. This medication is a cholinesterase inhibitor, which means it works by preventing the breakdown of acetylcholine at the neuromuscular junction. By keeping more acetylcholine available, pyridostigmine helps strengthen the signal from nerve to muscle, making it easier for muscles to contract and improving muscle strength. Some people can control their symptoms with pyridostigmine alone. The medication needs to be taken several times throughout the day for it to maintain its effect. Common side effects include diarrhea, abdominal cramps, nausea, and vomiting. Another medication called glycopyrrolate can be used to reduce these gastrointestinal side effects.[1][4]
If pyridostigmine is not effective enough on its own, or if symptoms are significantly interfering with daily life, corticosteroid medications such as prednisone are often prescribed. Steroids work by suppressing the immune system, reducing the production of the harmful antibodies that attack the neuromuscular junction. Prednisone can be very effective at controlling the symptoms of ocular myasthenia gravis. Steroids are typically started at a relatively high dose and then gradually reduced to the lowest dose that effectively controls symptoms. Improvement usually begins two to four weeks after starting treatment, with maximum benefit seen after six to twelve months. However, long-term use of steroids carries significant side effects, including osteoporosis (weakening of the bones), diabetes, high blood pressure, weight gain, mood changes, sleep disturbances, and increased risk of infections. Because of these side effects, doctors try to use the lowest effective dose and may add other medications to allow for lower steroid doses.[1][4][8]
Other immunosuppressive medications that help control the immune system can be used either alone or in combination with steroids. These are often referred to as steroid-sparing agents because they can allow for reduction in steroid dosage while maintaining symptom control. Common options include azathioprine (Imuran), mycophenolate mofetil (Cellcept), methotrexate, and cyclosporine (also spelled ciclosporin). Each of these medications works by dampening the immune response in different ways. They generally take longer to become effective compared to steroids, ranging from several weeks to several months, but they have more favorable long-term side effect profiles compared to high-dose steroids. Regular blood tests are required to monitor for potential side effects on the liver, kidneys, and blood counts.[1][4]
For people with more severe symptoms or those who are not responding well to standard medications, intravenous immunoglobulin (IVIg) can be used. IVIg consists of antibodies pooled from many donors and can modulate the immune system. It is given as an infusion into a vein and can provide relatively rapid improvement, although the effects are temporary. IVIg is typically reserved for more severe cases or for short-term use during periods of worsening symptoms.[1][7]
Non-Medication Strategies
In addition to medications, there are practical strategies that can help manage the visual symptoms of ocular myasthenia gravis. For double vision, wearing an eye patch over one eye can eliminate the double image by blocking the view from one eye. This restores single vision, though it does reduce depth perception. You can alternate which eye is patched to prevent strain in one eye. Some people find it helpful to use patches while reading or performing tasks that require clear vision.[19]
Another option for managing double vision is the use of prism lenses in eyeglasses. Prisms can bend light in a way that helps align the images seen by each eye, reducing or eliminating double vision. However, because the degree of eye muscle weakness and misalignment can fluctuate throughout the day in myasthenia gravis, prism glasses may be more effective in some situations than others. It can take some trial and error to find the most helpful prism prescription.[19]
For drooping eyelids, eyelid crutches can be attached to eyeglasses to physically hold the eyelids open, improving the field of vision. Some people find relief by temporarily taping their eyelids up using special light-adhesive tape designed for this purpose, which can be obtained from an eye doctor.[19]
Using sunglasses and visors to reduce glare can make visual tasks more comfortable. Protecting your eyes from bright light and harsh environmental conditions can reduce eye strain and fatigue.[19]
Lifestyle Adjustments
Resting your eyes regularly is important. Close your eyes for short periods when you feel they are getting tired, especially during activities that require sustained visual attention such as reading or computer work. Planning activities for times of day when your symptoms are typically milder can also help you function better.[16]
Pathophysiology
The pathophysiology of ocular myasthenia gravis involves a breakdown in normal communication between nerves and muscles at the neuromuscular junction. Understanding how this process is disrupted helps explain why the symptoms occur and how treatments work.[2]
In a healthy person, when the brain decides to move the eyes or blink, an electrical signal travels down a nerve toward the eye muscle. When this electrical signal reaches the end of the nerve, it triggers the release of acetylcholine into the narrow space between the nerve ending and the muscle, called the synaptic cleft. Acetylcholine molecules then diffuse across this gap and bind to special receptor proteins on the surface of the muscle cell. When enough acetylcholine receptors are activated, they trigger electrical changes in the muscle that cause it to contract, producing movement.[7]
In ocular myasthenia gravis, the immune system produces autoantibodies, primarily of the IgG1 and IgG3 subclasses, that target the acetylcholine receptor complex on the muscle membrane. These antibodies can interfere with neuromuscular transmission in several ways. They can block the receptor, preventing acetylcholine from binding. They can cause the receptors to be destroyed more rapidly than usual through a process involving complement activation, which damages the muscle membrane. They can also cause the receptors to be internalized and degraded inside the muscle cell, reducing the total number of receptors available on the muscle surface.[2][10]
When there are fewer functional acetylcholine receptors available, the muscle’s ability to respond to nerve signals is impaired. Initially, there may be enough receptors that the muscle can still contract normally. However, with repeated activation, as occurs during sustained eye movements or prolonged eyelid opening, the number of available receptors becomes insufficient, and the muscle begins to fatigue and weaken. This explains the characteristic pattern of symptoms that worsen with use and improve with rest.[5]
The extraocular muscles and eyelid muscles are particularly susceptible to this autoimmune attack for several reasons. These muscles have fewer acetylcholine receptors per neuromuscular junction compared to other skeletal muscles, making them more vulnerable when receptors are lost. Eye muscles also contract more rapidly and frequently than most other muscles in the body, which may make them more likely to become fatigued. Additionally, there may be differences in the structure of the neuromuscular junctions in eye muscles that make them respond differently to immune attack compared to muscles elsewhere in the body.[4]
The reason why the immune system begins producing these harmful antibodies is not completely clear. The thymus gland, which plays a critical role in the development and regulation of the immune system, is often abnormal in people with myasthenia gravis. Some researchers believe that abnormalities in the thymus may contribute to the development of the autoimmune response against acetylcholine receptors, though the exact mechanisms remain under investigation.[1]
Understanding this pathophysiology is important because it guides treatment strategies. Medications like pyridostigmine work by increasing the amount of acetylcholine available in the synaptic cleft, compensating for the reduced number of receptors. Immunosuppressive medications like steroids and other immune-modulating drugs work by reducing the production of the harmful antibodies or by dampening the overall immune response. Treatments like intravenous immunoglobulin and plasma exchange work by removing or neutralizing the circulating antibodies. Each approach targets a different aspect of the pathological process.[1][8]
